Back to search results

Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Abroad (travel likely)RecruitingPHASE2

Conditions

Decompensated Cirrhosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • The First Hospital of Lanzhou University, Lanzhou, Gansu, China

    Contact: Study coordinator (Xun Li) · lix@lzu.edu.cn

  • Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China

    Contact: Study coordinator (Qi Zhang) · zhangq27@mail.sysu.edu.cn

  • Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan, China

    Contact: Study coordinator (Ya-Li Zhao) · zhaoyl301@163.com

  • Jin Yin-tan Hospital, Wuhan, Hubei, China

    Contact: Study coordinator (Chaolin Huang) · 88071718@qq.com

  • Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality, China

    Contact: Study coordinator (Wei-Fen Xie, MD, PhD) · weifenxie@medmail.com.cn

  • Xinjiang Kashi Area Number 1 Hospital, Kashgar, Xinjiang, China

    Contact: Study coordinator (Fei Xiao) · xiaof35@sysu.edu.cn

  • Beijing 302 Hospital, Beijing, China

    Contact: Study coordinator (Lei Shi, MD, PhD) · shilei302@126.com · 86-10-66949623
Study leads

  • Fu-Sheng Wang, MD, PhD

    Study Chair

    Beijing 302 Hospital

View source on ClinicalTrials.gov(opens in a new tab)